Latest Cost Efficiency News

Wellard Limited reported a net profit of US$1.3 million for FY2025, driven by operational improvements and strategic asset sales. With the sale of its last livestock vessels completed, the company plans to delist from the ASX and return surplus cash to shareholders.

Experience Co Limited reports a robust FY25 with revenue growth and a significant jump in earnings, driven by a tourism rebound in Australia and New Zealand.

CTI Logistics reported modest revenue growth and a strong EBITDA increase in FY25, underpinned by a significant property valuation uplift and strategic capital investments. The company is poised for sustainable growth amid a consolidating freight market.

Algorae Pharmaceuticals reported a 62% reduction in net loss for FY2025, driven by R&D tax credits and cost efficiencies, while making significant strides in its AI drug discovery platform and therapeutic candidates.

Wiseway Group has reported a striking 66% increase in revenue for FY25, driven by robust expansion in its Imports and Overseas divisions alongside a nearly sevenfold rise in net profit before tax.

Hummgroup Limited reported a robust FY25 with cash profit soaring to $52.9 million, a significant reduction in costs, and a maintained historically low credit loss ratio. The group also completed a full repayment of its Perpetual Notes, signaling improved capital efficiency.

Future Generation Australia has raised its fully franked interim dividend for the tenth consecutive year, underpinned by a robust 10.8% investment portfolio return over the past 12 months.

Camplify Holdings reported a strategic refocus in FY25, delivering a strong operational turnaround in the second half and positioning itself for profitability in FY26. Despite a decline in gross transaction value, the company improved cost efficiency and expanded its membership and insurance offerings.

Nickel Industries reported a robust 81% rise in half-year profit to US$25.5 million, while advancing the Excelsior Nickel Cobalt project towards commissioning. The company also declared a final dividend and highlighted sustainability achievements.

FINEOS Corporation delivered solid first-half results with revenue growth and improved profitability, while navigating currency challenges that temper full-year guidance.

Vitasora Health reported a sharp rise in losses and operating cash outflows for FY2025, despite achieving significant cost savings from its Orb Health acquisition. The company faces a material uncertainty over its ability to continue as a going concern.

MoneyMe Limited reported a robust FY25 with a $1.6 billion loan book, 28% growth from FY24, and a $24 million operating cash profit, signaling a strong turnaround. The fintech lender also improved credit quality and expanded funding capacity, setting the stage for future growth.